Accretive Wealth Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,421
Closed -$1.74M 154
2025
Q1
$1.74M Buy
4,421
+129
+3% +$65.9K 0.62% 54
2024
Q4
$2.17M Sell
4,292
-15
-0.3% -$8.52K 0.92% 35
2024
Q3
$2.52M Sell
4,307
-202
-4% -$114K 1.05% 20
2024
Q2
$2.3M Buy
4,509
+50
+1% +$24.5K 0.96% 28
2024
Q1
$2.2M Buy
4,459
+22
+0.5% +$11.2K 0.97% 28
2023
Q4
$2.34M Buy
4,437
+16
+0.4% +$8.53K 1.12% 16
2023
Q3
$2.23M Buy
4,421
+16
+0.4% +$7.87K 1.33% 16
2023
Q2
$2.12M Buy
4,405
+52
+1% +$25.4K 1.26% 16
2023
Q1
$2.06M Buy
4,353
+44
+1% +$21.2K 1.32% 14
2022
Q4
$2.28M Buy
4,309
+334
+8% +$177K 1.57% 14
2022
Q3
$2.01M Sell
3,975
-8
-0.2% -$4.21K 1.53% 14
2022
Q2
$2.05M Sell
3,983
-9
-0.2% -$4.52K 1.49% 15
2022
Q1
$2.04M Sell
3,992
-37
-0.9% -$17.8K 1.28% 17
2021
Q4
$2.02M Buy
4,029
+90
+2% +$40.7K 1.29% 17
2021
Q3
$1.54M Buy
3,939
+144
+4% +$59.6K 1.09% 20
2021
Q2
$1.52M Buy
3,795
+239
+7% +$95.3K 1.1% 20
2021
Q1
$1.32M Buy
3,556
+256
+8% +$88.7K 1.19% 18
2020
Q4
$1.16M Buy
+3,300
New +$1.11M 1.14% 20

Other funds holding UNH

Accretive Wealth Partners's UNH Position: Q2 2025 in Review

Accretive Wealth Partners sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 4,421 shares — an estimated $1.74M sold.

Accretive Wealth Partners first reported a position in UNH in Q4 2020 and held it in 18 quarters. The position peaked at $2.52M in Q3 2024. 3,177 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Accretive Wealth Partners reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Accretive Wealth Partners sold 4,421 UnitedHealth shares in Q2 2025, an estimated $1.74M.
  • Accretive Wealth Partners first reported a position in UnitedHealth in Q4 2020 and held it in 18 quarters.
  • Accretive Wealth Partners's UnitedHealth position peaked at $2.52M in Q3 2024.
  • 3,177 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Accretive Wealth Partners's 13F filing for Q2 2025, filed 29 Jul 2025.